A rare variant of erythema nodosum leprosum: a case report.
We report a patient with lepromatous leprosy who developed a rare variant of type-2 lepra reaction, characterized by pustular lesions, on switching from WHO multi drug therapy (MDT) to ofloxacin-aided MDT.
Dave
Shriya
S
Department of Dermatology and STD, JIPMER, Pondicherry, India.
Thappa
Devinder M
DM
Nori
Achyuta Vithal
AV
Jayanthi
S
S
D000038:Abscess / Q000209:etiology; D000328:Adult; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004893:Erythema Nodosum / Q000139:chemically induced / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D008264:Macrophages / Q000473:pathology; D008297:Male; D008543:Melanins / Q000032:analysis; D008911:Minocycline / Q000008:administration & dosage / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D009504:Neutrophils / Q000473:pathology; D015242:Ofloxacin / Q000009:adverse effects* / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014657:Vasculitis / Q000139:chemically induced
D007917:Leprostatic Agents; D008543:Melanins; D014409:Tumor Necrosis Factor-alpha; D015242:Ofloxacin; D008911:Minocycline; D012293:Rifampin